Encelimab
Modify Date: 2024-01-12 18:19:45
Encelimab structure
|
Common Name | Encelimab | ||
|---|---|---|---|---|
| CAS Number | 2173096-82-5 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of EncelimabEncelimab is an anti-LAG3 antibody. Encelimab blocks the interaction between LAG-3 and MHC II, and enhances T-cell activation. Encelimab alone or in combination with an anti-PD-1 antibody reduces tumor size in a lymphoma mice model (A20 cell xenograft)[1]. |
| Name | Encelimab |
|---|
| Description | Encelimab is an anti-LAG3 antibody. Encelimab blocks the interaction between LAG-3 and MHC II, and enhances T-cell activation. Encelimab alone or in combination with an anti-PD-1 antibody reduces tumor size in a lymphoma mice model (A20 cell xenograft)[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |